← Back to Clinical Trials
Recruiting NCT06206200

NCT06206200 The Effects of Cognitive Dual-Tasking in Later Stages of Rehabilitation After ACL Reconstruction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06206200
Status Recruiting
Phase
Sponsor University Ghent
Condition Anterior Cruciate Ligament Reconstruction
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2023-10-15
Primary Completion 2027-04-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Cognitive dual task training (intervention group)Standard of care physiotherapy (control group)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2023-10-15 with a primary completion date of 2027-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Anterior cruciate ligament (ACL) injuries are common in sports and often require a long and challenging rehabilitation process. Athletes who sustain these injuries typically engage in pivoting and cutting sports, where these motor tasks must be performed simultaneously with cognitive tasks such as decision-making and keeping an eye on the opponent. Directing attention to both cognitive and motor tasks leads to cognitive-motor interference, which is associated with movement patterns that increase the risk of ACL (re)injury. Therefore, it is crucial that before returning to such demanding sports after ACL reconstruction, athletes sufficiently develop and automate safe yet efficient motor skills to free up attentional capacity for decision-making, thereby reducing the risk of suboptimal movement patterns and reinjury. However, current rehabilitation programs often primarily focus on the motor component in a single-task manner, giving insufficient attention to the cognitive component that is inseparable from sports. This randomized controlled trial aims to investigate the effects of implementing motor-cognitive dual tasks in the end phase rehabilitation after ACL reconstruction on muscle function, functional outcomes, and patient-reported outcomes.

Eligibility Criteria

Inclusion Criteria: * 18-40 years old. * Having suffered an ACL rupture. * Undergoing a surgical ACL reconstruction in the AZ Delta hospital in Roeselare (Campus Brugsesteenweg). Exclusion Criteria: * Revision ACL reconstruction. * Other severe injuries to the lower limbs within the past year. * Muscle or neurological disorders affecting lower limb functioning. * Fibromyalgia or chronic fatigue syndrome.

Contact & Investigator

Central Contact

Evy Deschaumes, MSc

✉ evy.deschaumes@ugent.be

📞 +32 9 332 5503

Frequently Asked Questions

Who can join the NCT06206200 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Anterior Cruciate Ligament Reconstruction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06206200 currently recruiting?

Yes, NCT06206200 is actively recruiting participants. Contact the research team at evy.deschaumes@ugent.be for enrollment information.

Where is the NCT06206200 trial being conducted?

This trial is being conducted at Roeselare, Belgium.

Who is sponsoring the NCT06206200 clinical trial?

NCT06206200 is sponsored by University Ghent. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology